Better Access Key To Higher Survival For African-Americans With Colon Cancer
NCI Grant Supports Jefferson Trial To Study Test To Diagnose Colorectal Cancer Spread
Lung Cancer Survivors Claim Good QOL, Despite Challenges
“Acceptable” Images Found In Chest Scans Using Half Dose
More Radiation Increases Prostate Cancer Response
More Workers Quit Smoking When Health Messages Combined
Local Labs Not As Accurate As Central Testing For HER2
FDA Approves Aranesp For Chemo-Induced Anemia
Clinical Trials Approved By NCI CTEP During July
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
